2.75% and Cms-linked Notes due 04/01/2030 (67JE)

https://www.hampshirechronicle.co.uk/news/26185479.university-winchester-wins-cyber-security-funding/
I'll teach them a thing or two - W.A.V.E.

https://www.universiteitleiden.nl/en/news/2026/06/how-do-you-prepare-for-the-threats-of-tomorrow
Easy - ACT NOW WITH WAVE.

Sagacious = “Showing unusually good judgment before everyone else sees it.”
It’s not just “smart.”
It’s smart at the right time, before the crowd, based on insight rather than hype.

When investors call a move sagacious, they mean:

You recognized the under

https://cybersecuritynews.com/optinmonster-plugin-exposes-wordpress-sites/
ACT NOW WITH WAVE.

One must be a believer around here, as reflected by the emojis. To some an idea is more important than fact.

The shell announcement wasn’t falling out of heaven. Everything has a reason. As told earlier this announcement wil trigger new serious investors!

EMBR…YEP! This is the calm before the storm. Here’s a company post.TWO definitive agreements signed and more updates coming….

https://x.com/embarrdownsinc/status/2065463502832382124?s=46

EMBR…YEP! This is the calm before the storm. Here’s a company post.TWO definitive agreements signed and more updates coming….

https://x.com/embarrdownsinc/status/2065463502832382124?s=46

“Our corporate headquarters are located at 4800 Montgomery Lane, Bethesda, Maryland, where we lease and occupy an aggregate of approximately 7,097 square feet of office space. The lease covering this property is currently scheduled to expire in August 2026.”

Well the property marketin

https://www.gov.uk/government/news/unique-liaison-programme-set-to-reinforce-close-collaboration-between-mhra-and-fda?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=95982d69-cc79-409a-a44a-cac5e2e70ff4&utm_content=immediately

KBR Launches Inaugural Innovation Studio Powered by Applied Computing in BengaluruJune 16, 2026 3:35 AM
PR Newswire (US) class="legendSpanClass"BENGALURU, India, class="legendSpanClass"June 16, 2026 /PRNewswire/ -- KBR (NYSE: KBR) launch

I don't see any end in sight for the insatiable demand for compute and data centers, to the contrary, demand is going parabolic.

Qualcomm CEO says AI agents will replace apps — as chip giant works on 40 new AI-powered devices
PUBLISHED TUE, JUN 16 20261:08 AM EDT

GPUS Everyone should keep an eye on this one; GPUS should continue to rise over the coming days and weeks. And once a deal is announced, the stock’s real future should truly take off—driven by strong revenue and massive profits. imho ,🚀 https://investorshub.advfn.com/boards/read_msg.aspx?me

WOW! Umpteenth dilution. Another umpteenth times to go. Well done.
Didn't know being a CEO and managing a company is this easy, as far as AMC is concerned. You earn money or lose money, doesn't matter. There is always dilution.

If retail shareholders oppose another dilution, t

GPUS
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177706706

GPUS Everyone should keep an eye on this one; GPUS should continue to rise over the coming days and weeks. And once a deal is announced, the stock’s real future should truly take off—driven by strong revenue and massive profits. imho ,🚀 https://investorshub.advfn.com/boards/read_msg.aspx?me

Yes, I understand. Even if you combine all of that, can it beat Dupixent? Alteogen only collaborates with the best companies. On the other hand, Halozyme has signed contracts with companies that I don't even know if they are actually working with. So, it's not Alteogen signing with junk, but Halozym

Herbal Dispatch Provides Update on Domestic Retail Operations and Proprietary Brand ExpansionJune 16, 2026 3:01 AM
NewsfileVancouver, B

The Strategic Verdict

This Forbes article is a massive structural validation for long-term Lightwave shareholders. For years, the bears argued that Lightwave was a standalone science project trying to force its way into the market.

Now, the U.S. government and GlobalFou

11/06 , maybe you're right!

Here are a few of those drugs:
Ebglyss (IL-13)Adbry (IL-13)Nemluvio (IL-31 receptor)Late-stage agents such as zumilokibart. 

When was it publiced? Maybe this why on 12june there was a huge spike on Jan 2027 15 options??

You ate wrong again! Not all Halozyme targets are public info for obvious competitive reasons.
There are number of other drugs in the class of Dupixent that halozyme might have an exclusive non-disclosed contract for. Here are a few of those drugs: